Biotechnology

Initial human trial results for an experimental cellular rejuvenation treatment targeting glaucoma show visual improvements in two patients, marking a milestone in cellular reprogramming research backed by tech billionaires.

Anthropic has secretly established a wet lab in the San Francisco Bay Area to expand into life sciences and drug discovery using AI, combining Claude with robotic systems for pre-clinical research.

Israeli startup Plantopia inaugurated a pilot plant at kibbutz Sdot Yam to produce dairy proteins from oat sprouts, following a $9 million funding round backed by Schreiber Foods.

The US FDA has launched the Expedited IND Pilot program to accelerate clinical trial approvals, shortening the lengthy preparation process for new drug developments.

Researchers from Stanford and the Arc Institute used artificial intelligence to design the genetic code of bacteriophages — viruses that attack bacteria — and created active viruses from them in the lab. This achievement could help in developing treatments against antibiotic-resistant bacteria, but experts warn that the improving ability of AI to design biological systems raises urgent questions...

If science extends our lives to 180 years, who exactly will the person we become be? Researchers from 300 universities have made an amazing discovery: there are topics other than the Palestinians. Also: the absurd parallel between Benjamin Netanyahu and Hitler, and the crisis in modern love songs.

Remepy has raised $36 million in a Series A funding round. The startup develops hybrid drugs that combine prescription medication with AI-based therapeutic applications.

After an exceptionally strong quarter, the Israeli company is raising its forecasts for 2026 and presenting dramatic clinical data for the treatment of PTSD and clinical depression, alongside a huge backlog of orders.

Researchers from Stanford University have achieved a scientific breakthrough by using artificial intelligence to design "from scratch" completely new viruses. The creation process utilized principles similar to those of advanced language models like ChatGPT.

New preclinical data indicate that the SIL204 treatment acts on three key mechanisms by which cancer tumors evade the immune system, strengthening the scientific basis for combination immunotherapy.

Scribe Therapeutics stock recorded a sharp jump of nearly 49% on its first day of trading following a successful IPO pricing. Global pharmaceutical giants Sanofi and Eli Lilly have allocated significant capital to invest in the company.